Jim Yip, co-founder of Elixir  Biotech Real Estate, talks about his Passion for Innovation. 

Beginning of this year three of us create a company Elixir with an ambition to embark on a new journey of innovation in China’s life science real estate.

Simply because we see

a spectacular growth in life science industry in recent years.

and an amazing opportunity in the sector’s infrastructure development- R&D labs and specialised manufacturing facilities – on the back of industry’s new growth.

Even more exciting, a number of  innovations Elixir can create for clients and help them transform a new treatment in life science properties.

For Funds/LPs– one-stop shop approach in one single asset class, powerful industry-based service, well-connected industry resource.

For Pharma Companies – from inventory to investment property, new capital and approach in asset ownership.

For Government– market-oriented ilife science center developments to attract the leading companies , technologies, and talents, create jobs and social wealth.

The life science industry is re-writing its gene code of real estate, driving Innovation in Property, Operation, and Capital!

We at Elixir commit to be part of this revolution.